化疗所致周围神经病变的机制与治疗
摘要
药物化疗引起的周围神经病变，被称为化疗相关性周围神经病变（chemotherapy-induced peripheral neuropathy, CIPN），其
中典型的临床症状之一即为疼痛。CIPN 导致等疼痛在化疗过程中即可出现，可在化疗结束后仍持续相当长的一段时间，
对器官功能和生活质量有持续且长久的负面影响。目前已有相当多的研究致力于寻找预防或治疗 CIPN 的方法，本文总结
了近年的相关研究，以期为临床实践提供帮助。
关键词
全文:
PDF参考
[1] 王玉栋 , 杜玉娟 , 刘巍 . 化疗致周围神经病变的临床
治疗 [J]. 中国疼痛医学杂志 , 2011, 17(8): 5.
[2] 梁翠绿 , 张吟 , 陈文发 . 药物防治化疗所致周围神经
病变的临床研究进展 [J]. 中国现代应用药学 , 2021.
[3]Omran M, Belcher E K, Mohile N A, et al. Review of
the Role of the Brain in Chemotherapy-Induced Peripheral
Neuropathy[J]. Front Mol Biosci, 2021, 8: 693133.
[4]Was H, Borkowska A, Bagues A, et al. Mechanisms of
Chemotherapy-Induced Neurotoxicity[J]. Front Pharmacol, 2022,
13: 750507.
[5]Molassiotis A, Cheng H L, Lopez V, et al. Are we mis-
estimating chemotherapy-induced peripheral neuropathy?
Analysis of assessment methodologies from a prospective,
multinational, longitudinal cohort study of patients receiving
neurotoxic chemotherapy[J]. BMC Cancer, 2019, 19(1): 132.
[6]Loprinzi C L, Lacchetti C, Bleeker J, et al. Prevention and
Management of Chemotherapy-Induced Peripheral Neuropathy
in Survivors of Adult Cancers: ASCO Guideline Update[J]. J Clin
Oncol, 2020, 38(28): 3325-3348.
[7]Smith E M L, Pang H, Cirrincione C, et al. CALGB
170601: A phase III double blind trial of duloxetine to treat
painful chemotherapy-induced peripheral neuropathy (CIPN)[J],
2012, 30(18_suppl): CRA9013.
[8]Knijn N, Tol J, Koopman M, et al. The effect of
prophylactic calcium and magnesium infusions on the incidence of
neurotoxicity and clinical outcome of oxaliplatin-based systemic
treatment in advanced colorectal cancer patients[J]. Eur J Cancer,
2011, 47(3): 369-74.
[9]Ao R, Wang Y H, Li R W, et al. Effects of calcium
and magnesium on acute and chronic neurotoxicity caused by
oxaliplatin: A meta-analysis[J]. Exp Ther Med, 2012, 4(5): 933-
937.
[10]Zhou L, Liu R, Huang D, et al. Monosialotetrahexosylgan
glioside in the treatment of chronic oxaliplatin-induced peripheral
neurotoxicity: TJMUCH-GI-001, a randomised controlled trial[J].
EClinicalMedicine, 2021, 41: 101157.
[11]Wu S, Bai X, Guo C, et al. Ganglioside-monosialic
acid (GM1) for prevention of chemotherapy-induced peripheral
neuropathy: a meta-analysis with trial sequential analysis[J]. BMC
Cancer, 2021, 21(1): 1173.
[12]De Andrade D C, Jacobsen Teixeira M, Galhardoni R, et
al. Pregabalin for the Prevention of Oxaliplatin-Induced Painful
Neuropathy: A Randomized, Double-Blind Trial[J]. Oncologist,
2017, 22(10): 1154-e105.
[13]Kim B S, Jin J Y, Kwon J H, et al. Efficacy and safety
of oxycodone/naloxone as add-on therapy to gabapentin or
pregabalin for the management of chemotherapy-induced
peripheral neuropathy in Korea[J]. Asia Pac J Clin Oncol, 2018,
14(5): e448-e454.
[14]Rossignol J, Cozzi B, Liebaert F, et al. High concentration
of topical amitriptyline for treating chemotherapy-induced
neuropathies[J]. Support Care Cancer, 2019, 27(8):3053-3059.
[15]Privitera R, Anand P. Capsaicin 8% patch Qutenza and
other current treatments for neuropathic pain in chemotherapy-
induced peripheral neuropathy (CIPN)[J]. Curr Opin Support
Palliat Care, 2021, 15(2): 125-131.
[16]Kleckner I R, Kamen C, Gewandter J S, et al. Effects
of exercise during chemotherapy on chemotherapy-induced
peripheral neuropathy: a multicenter, randomized controlled
trial[J]. Support Care Cancer, 2018, 26(4): 1019-1028.
[17]Lin W L, Wang R H, Chou F H, et al. The effects
of exercise on chemotherapy-induced peripheral neuropathy
symptoms in cancer patients: a systematic review and meta-
analysis[J]. Support Care Cancer,2021,29(9): 5303-5311.
[18] 张 奇 文 , 王 斌 , 潘 玥 ,et al. 近 10 年 针 灸 治 疗 化
疗 所 致 周 围 神 经 病 变 的 临 床 研 究 进 展 [J]. 上 海 针 灸 杂
志 ,2016,35(9):5.
[19]Yang Y, Zhang R, Zhong Z, et al. Efficacy of
transauricular vagus nerve stimulation for the treatment of
chemotherapy-induced painful peripheral neuropathy: a
randomized controlled exploratory study[J]. Neurol Sci,2024,
45(5):2289-2300.
(5 摘要 Views, 16 PDF Downloads)
Refbacks
- 当前没有refback。